Expert Opin Investig Drugs 32(5):355359 Urva S, Coskun T, Loh MT, Du Y, Thomas MK, Gurbuz S et al (2022) LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
This can be especially problematic around the abdomen
If youve ever eaten a tiny meal and felt weirdly stuffed for hours, Bi-07 is the strain people swear helps take the edge off
If you miss a dose, follow the instructions
Retatrutide works by mimicking natural hormones that regulate appetite and metabolism